Search company, investor...
Search
Cubresa company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

cubresa.com

Founded Year

2011

Stage

Unattributed | Alive

Total Raised

$580K

About Cubresa

Cubresa provides planar gamma and SPECT imaging solutions for the diagnostic, surgical, and pre-clinical imaging marketplace. The company is focused on serving a diverse range of customers, such as hospitals, medical imaging system providers, laboratory system providers, and scientists. Cubresa supplies its products on OEM, Custom, and End Market basis.

Cubresa Headquarters Location

800 – 136 Market Avenue

Winnipeg, Manitoba, R3B 0P4,

Canada

1-204-272–2409

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Cubresa Patents

Cubresa has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/14/2013

4/26/2016

Medical imaging, Particle detectors, Medical physics, Sensors, Ionising radiation detectors

Grant

Application Date

2/14/2013

Grant Date

4/26/2016

Title

Related Topics

Medical imaging, Particle detectors, Medical physics, Sensors, Ionising radiation detectors

Status

Grant

Latest Cubresa News

SPECT Scanning Services Market is expected to expand at an average CAGR of 7.8% and reach US$ 4,434.8 Million by 2032

Aug 17, 2022

Search jobs 17-Aug-2022 SPECT Scanning Services Market is expected to expand at an average CAGR of 7.8% and reach US$ 4,434.8 Million by 2032 [333 Pages Report] The global  SPECT scanning services market  is worth US$ 1,950.6 Million in 2022. The SPECT scanning services market is expected to expand at an average CAGR of 7.8% and reach US$ 4,434.8 Million by 2032. According to the latest report by Future Market Insights on global SPECT Scanning Services market, the market is expected to register the growth of xx% CAGR through 2021 and beyond. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on SPECT Scanning Services market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the SPECT Scanning Services market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Critical Questions Answered in the Report What are ongoing trends that will shape market growth curve for global SPECT Scanning Services market? What are the drivers and challenges affecting the SPECT Scanning Services market demand? What are the recent technological advancement in the SPECT Scanning Services market? What are key trends and opportunities that will prevail the revenue growth of SPECT Scanning Services market players? How will evolving regulatory policies impact the market growth? What is the impact of Covid-19 on the SPECT Scanning Services market? Get Free Sample Report of SPECT Scanning Services Market @  https://www.futuremarketinsights.com/reports/sample/rep-gb-4122 Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics. The report offers extensive data sets validating key trends impacting growth in the SPECT Scanning Services market. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of SPECT Scanning Services market. With our extensive research and information about the past, current and future market scenario, the SPECT Scanning Services market report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises. Understanding the Impact of Covid-19 on Healthcare Industry With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance. The FMI’s latest report on the SPECT Scanning Services market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic. Ask from the Market Research Expert @  https://www.futuremarketinsights.com/ask-question/rep-gb-4122 SPECT Scanning Services Market: Segmentation SPECT scanning services market is classified on the basis of radioisotope type, application, end user and region Based on type of radioisotope, the SPECT scanning services market is segmented into the following: Iodine-123 Brain Disorders Hospitals Cubresa Inc. and Others With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the SPECT Scanning Services market Why Future Market Insights? Detailed insights of market segments and sub-segments for historical as well as forecast period A competitive analysis of prominent players and emerging players in the SPECT Scanning Services market Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario About FMI: Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years. Contact Us:

  • When was Cubresa founded?

    Cubresa was founded in 2011.

  • Where is Cubresa's headquarters?

    Cubresa's headquarters is located at 800 – 136 Market Avenue, Winnipeg.

  • What is Cubresa's latest funding round?

    Cubresa's latest funding round is Unattributed.

  • How much did Cubresa raise?

    Cubresa raised a total of $580K.

  • Who are the investors of Cubresa?

    Investors of Cubresa include Manitoba Knights, Manitoba Technology Accelerator and Research Manitoba.

  • Who are Cubresa's competitors?

    Competitors of Cubresa include SynchroPET.

You May Also Like

L
Lucerno Dynamics

Lucerno Dynamics manufactures medical technology that helps scan human tissue and organs during medical tests. The company was founded in 2011 and is based in Cary, North Carolina.

SynchroPET Logo
SynchroPET

SynchroPET is developing a next-generation positron emission technology (PET) with multiple applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.